Related Experiment Video
Updated: Sep 16, 2025

09:16
Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro
Published on: November 26, 2018
7.2K
Monocyte Involvement in the Pathogenesis of Myeloproliferative Neoplasms
Xuedong Li1,2, Mingli Xu1,2, Yingying Wang1,2
1Department of Immunology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.
International Journal of Molecular Sciences
|July 12, 2025
Summary
Aberrant monocytes are implicated in myeloproliferative neoplasms (MPNs), such as primary myelofibrosis (PMF). This review explores monocyte heterogeneity and their role in MPN development and progression.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Classical BCR-ABL-negative myeloproliferative neoplasms (MPNs) are a diverse set of blood cancers.
- Monocytes, crucial immune cells, display heterogeneity and regulate immune responses.
- Altered monocytes are linked to MPN prognosis and pathogenesis, especially in primary myelofibrosis (PMF).
Purpose of the Study:
- To investigate the heterogeneity of monocyte subsets in homeostasis.
- To elucidate the mechanisms by which monocytes contribute to MPN development and progression.
Main Methods:
- Literature review of studies on monocyte heterogeneity.
- Analysis of monocyte subset பங்களிப்பு in MPN pathogenesis.
- Exploration of immune regulatory functions of monocytes in MPNs.
Main Results:
- Monocyte subsets exhibit significant heterogeneity during homeostasis.
- Aberrant monocytes are associated with poor prognosis in MPNs, particularly PMF.
- Altered monocytes play a key role in the development and progression of MPNs.
Conclusions:
- Understanding monocyte heterogeneity is crucial for MPN research.
- Targeting aberrant monocyte functions may offer therapeutic strategies for MPNs.
- Further research into monocyte mechanisms in MPNs is warranted.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Disorders of Leukocytes
1.2K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.2K
Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K

